findmyKOL
Clinical trialNCT02089464CompletedInterventional

Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial

SponsorNexstim LtdEnrollment199Stroke
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A pivotal, prospective, multi-center, randomized, controlled, double-blinded study combining active Nexstim NBS-guided 1Hz rTMS or sham-rTMS targeting the healthy hemisphere with standardized task oriented rehabilitation will be conducted in patients with post-stroke motor impairment. The therapy will be provided for 6 weeks and primary outcome assessed 6 months later.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Mayo Clinic

    Phoenix, Arizona, United States

  • Rancho Los Amigos National Rehabilitation Center

    Downey, California, United States

  • Shepherd Rehabilitation Center

    Atlanta, Georgia, United States

  • Rehabilitation Institute of Chicago

    Chicago, Illinois, United States

  • Indiana University Indianapolis

    Indianapolis, Indiana, United States

  • Spaulding Rehabilitation Hospital

    Boston, Massachusetts, United States

  • Columbia Cornell New York Presbyterian Hospital

    New York, New York, United States

  • Burke Medical Research Institute, Weill Cornell Neurology

    White Plains, New York, United States

  • Duke University Medical Center

    Durham, North Carolina, United States

  • University of Cincinnati

    Cincinnati, Ohio, United States

  • Ohio State University

    Columbus, Ohio, United States

  • Tirr Memorial Hermann Hospital

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2014
Primary completion
31 May 2016
Completion
31 May 2016
Last update posted
1 Sept 2020
Registered enrollment
199
Registry id
NCT02089464
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.